References

  1. Dykstra DD, Sidi AA, Scott AB, Pagel JM, Goldish GD. Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients. J Urol. 1998; 139(5): 919-922. PubMed | Google Scholar

  2. Schurch B, Schmid DM, Stohrer M. Treatment of neurogenic incontinence with botulinum toxin. A N Eng J Med. 2000; 342: 665. PubMed | Google Scholar

  3. Larson TR, Scottsdale AZ, Huidobro C, Acevedo C. Intraprostatic injection of toxin in the treatment of symptomatic LUTS, including sequential MRIs for acute changes in size of the prostate. J Urol. 2005; 173 : 376. PubMed | Google Scholar

  4. Grise P, Daoudi Y, Tanneau Y, Sibert L. Principes d'action et indication de la toxine botulique dans le traitement de l'hyperactivité vésicale. Ann Urol. 2005; 39(3-4): 105-115. PubMed | Google Scholar

  5. Drake MJ. Mechanisms of action of Intravesical botulinum treatment in refractory detrusor overactivity. BJU Int. 2008; 102(Suppl 1):11-6. PubMed | Google Scholar

  6. Chartier-Kastler E, Castro-Diaz D, De Ridder D, Everaert K, Sievert KD, Spinelli M et al. Le point sur les traitements de seconde ligne de l'hyperactivité vésicale idiopathique. Prog Urol. 2009; 19(8):530-7. PubMed | Google Scholar

  7. Setler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain. 2002; 18(6): S119-124. PubMed | Google Scholar

  8. Brooks VB. Motor nerve filament block produced by botulinum toxin. Science. 1953; 117(3039): 334-339. PubMed | Google Scholar

  9. Scott AB, Rosenbaum A, Collins CC. Pharmacologic weakening of extraocular muscles. Invest Ophthalmol. 1973; 12(12): 924-927. PubMed | Google Scholar

  10. Scott AB. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus. 1980; 17(1): 21-25. PubMed | Google Scholar

  11. Rapp DE, Lucioni A, Katz EE, O'connor RC, Gerber Gs, Bales GT. Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms : an initial experience. Urology. 2004; 63(6): 1071-1075. PubMed | Google Scholar

  12. Maria G, Brisinda G, Civello IM, Bentivoglio AR, Sganga G, Albanese A. Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia: results of a randomized, placebocontrolled study. Urology. 2003; 62(2): 259-264. PubMed | Google Scholar

  13. Guercini, Giamantoni A, Bard RL. Intraprostatic botox: an injection in patients with severe benign prostatic hyperplasia: A multicenter study. J Urol. 2005; 173: 376-377. Google Scholar

  14. Chuang YC, Chiang PH, Huang CC, Yoshimura N, Chancellor MB. Botulinum toxin type A improves benign prostatic hyperplasia symptoms in patients with small prostates. Urology. 2005; 66(4): 775-779. PubMed | Google Scholar

  15. Silva J, Silva C, Saraiva L, Silva A, Pinto R, Dinis P et al. Intraprostatic botulinum toxin type a injection in patients unfit for surgery presenting with refractory urinary retention and benign prostatic enlargement: Effect on prostate volume and micturition resumption. Eur Urol. 2008;53(1):153-9. PubMed | Google Scholar

  16. Kuo HC. Prostate botulinum A toxin injection - an alternative treatment for benign prostatic obstruction in poor surgical candidates. Urology. 2005;65(4):670-4. PubMed | Google Scholar